Browse & search snapshots

ARCHIVED - Opioid Analgesic Abuse (OAA) We have archived this page and will not be updating it. You can use it for research or reference. We have archived this page and will not be updating it. You can use it for research or reference. Terms of Reference 2011-02-22 Membership…

ARCHIVED - Bioequivalence Requirements for Modified-Release Dosage Forms (SAP-MRDF) We have archived this page and will not be updating it. You can use it for research or reference. We have archived this page and will not be updating it. You can use it for research or reference.…

Bioequivalence Requirements for Gender-Specific Drug Products (GSDP) Terms of Reference 2011-06-02 Membership Membership List and Biographies Summary of Expertise, Experience and Affiliations and Interests Meetings 2011-06-02 Agenda Record of Procedings Page details 2017-05-04

Anti-infective Therapies Scientific Advisory Panel on Anti-infective Therapies (SAP-AIT) Announcement of Meeting Announcement of Meeting Agenda Terms of Reference Terms of Reference Membership Summary of Expertise, Experience and Affiliations and Interests Membership List…

Scientific/Expert Advisory Panels Scientific Advisory Bodies For materials from past meetings of active panels and panels that are dormant, or whose mandate is completed, please contact Policy Bureau Enquires for additional information. Scientific / Expert Advisory Panel Status…

Registration and Disclosure of Clinical Trial Information Phase 1: 2005 Consultation Phase 2: 2006 Consultation What is a clinical trial? A clinical trial is an investigation of a drug for use in humans and involves human subjects. It determines the level of safety and efficacy…

Notice of Compliance Listings Important Notice: The NOC Data Extract is now online and will be updated weekly, every Friday. The NOC lists are available in two formats, ASCII Text, and a "comma-delimited" database-text format (DBF) that can be imported into most database software…

Memorandum of Understanding 2005-03-24 (PDF Version - 877 K) Contact: Policy Bureau Enquiries Memorandum of Understanding concerning streamlined processes for regulatory amendments to Schedule F to the Food and Drug Regulations and to Table II, Division 15, Part B, of the Food…

Canada Gazette Part II The following regulatory proposals have been made into regulations and are published in Canada Gazette Part II . The publication contains the rationale for the regulatory proposal, the final regulations and the effective date. To facilitate a search, use…

Canada Gazette Part I The following proposed regulatory amendments and Regulatory Impact Analysis Statement ( RIAS ) were recently pre-published in the Canada Gazette Part I for public consultation. Readers are invited to provide comments on these proposals within the time period…